HARMONY BIOSCIENCES TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES

Rhea-AI Summary

Harmony Biosciences Holdings, Inc. (NASDAQ: HRMY), a pharmaceutical company dedicated to rare neurological diseases, will participate in upcoming investor conferences. These include the Wells Fargo Healthcare Conference on September 7, 2022, featuring a fireside chat at 2:35 p.m. ET and 1x1 meetings. Additionally, the Citi's 17th Annual BioPharma Conference will take place in Boston on the following day with similar 1x1 meetings. A webcast of the fireside chat will be available on Harmony's investor page.

PLYMOUTH MEETING, Pa., Aug. 17, 2022 /PRNewswire/ -- Harmony Biosciences Holdings, Inc. ("Harmony" or the "Company") (NASDAQ: HRMY), a pharmaceutical company focused on delivering innovative therapies that improve the health of people living with rare neurological diseases, today announced that Harmony's management will participate in the following upcoming investor conferences:

2022 Wells Fargo Healthcare Conference

• Location: Boston, MA
• Fireside Chat: Wednesday, September 7, 2022, at 2:35 p.m. ET
• 1x1 Meetings: Wednesday, September 7, 2022

Citi's 17th Annual BioPharma Conference

• Location: Boston, MA
• 1x1 Meetings: Thursday, September 8, 2022

A webcast of the Wells Fargo Healthcare Conference fireside chat will be available on the investor page of Harmony's website at https://ir.harmonybiosciences.com/.

About Harmony Biosciences

At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook. We believe that where empathy and innovation meet, a better life can begin for people living with neurological diseases. Established by Paragon Biosciences, LLC, in 2017 and headquartered in Plymouth Meeting, PA, our team of experts from a wide variety of disciples and experiences is driven by our shared conviction that innovative science translates into therapeutic possibilities for our patients, who are at the heart of everything we do. For more information, please visit www.harmonybiosciences.com.

Harmony Biosciences Investor Contact:
Luis Sanay, CFA
445-235-8386
lsanay@harmonybiosciences.com 

Harmony Biosciences Media Contact:
Nancy Leone
215-891-6046
nleone@harmonybiosciences.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/harmony-biosciences-to-participate-in-upcoming-investor-conferences-301607141.html

SOURCE Harmony Biosciences

FAQ

What conferences will Harmony Biosciences attend in September 2022?

Harmony Biosciences will attend the Wells Fargo Healthcare Conference on September 7, 2022, and Citi's 17th Annual BioPharma Conference on September 8, 2022.

When is Harmony Biosciences' fireside chat scheduled?

The fireside chat at the Wells Fargo Healthcare Conference is scheduled for September 7, 2022, at 2:35 p.m. ET.

Where can I watch the Harmony Biosciences fireside chat?

The webcast of Harmony Biosciences' fireside chat will be available on their investor page at https://ir.harmonybiosciences.com/.

What is the focus of Harmony Biosciences?

Harmony Biosciences focuses on developing innovative therapies for rare neurological diseases.

What is the stock symbol for Harmony Biosciences?

Harmony Biosciences is listed on NASDAQ under the stock symbol HRMY.